KUALA LUMPUR: Medical devices and solutions provider LAC Med Bhd
has received approval from the Securities Commission Malaysia (SC) to proceed with its initial public offering (IPO) and listing on the Main Market of Bursa Malaysia.
In a statement today, group chief executive officer Liew Yoon Poh said the SC’s approval marks the beginning of the group’s next phase of growth opportunities.
"As LAC Med taps into the capital market, we aim to establish new business segments and expand our market presence in Indonesia. Above all, we remain committed to creating long-term value for the healthcare industry, as well as for our stakeholders and customers,” he said.
The company, which provides end-to-end services for the supply and integration of medical device solutions, said it currently supports more than 300 active clients across Malaysia’s healthcare sector.
These include private and public healthcare institutions, universities, local health offices, medical device suppliers, and concessionaire companies.
RHB Investment Bank Bhd is the principal adviser, sole underwriter, and sole placement agent for the IPO exercise. - Bernama
